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Objective. To examine social variations in parental rationales for delaying or forgoing human papillomavirus
vaccination in their U.S. adolescent children.
Methods. Using data from the 2011 National Immunization Survey–Teen, we estimated a series of binary
logistic regression models to predict the odds of reporting (1) any vaccine delay (n = 25,229) and (2) speciﬁc
rationales among parents who reported that they were “not likely at all” to vaccinate their teen (n= 9,964).
Results. The odds of not receiving a recommendation to vaccinatewere higher in parents of boys (OR= 2.57;
CI = 2.20–3.01). The odds of reporting a lack of knowledge were higher in parents who identiﬁed as Hispanic
(OR = 1.39; CI = 1.11–1.72), Black (OR = 1.49; CI = 1.19–1.85), and other races (OR = 1.43; CI = 1.13–
1.80) than parents who identiﬁed as non-Hispanic White. Socioeconomic disparities in parental rationales for
delaying human papillomavirus vaccination in their teen children were sporadic and inconsistent.
Conclusion.Our results suggest that interventions should focus on increasing information about the beneﬁts of
the human papillomavirus vaccine among parents of minority youth. Our ﬁndings also suggest that interventions
targeting health care providers may be a useful strategy for improving vaccine uptake among adolescent males.© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
Human papillomavirus (HPV), which can cause cervical cancer,
genital warts, and other anogenital cancers, is themost common sex-
ually transmitted infection in the United States (Weinstock et al.,
2004). Among females 14–59 years of age, over a quarter are infect-
ed with at least one strain of HPV(Dunne et al., 2007). The virus is
also prevalent among sexually active males (Dunne et al., 2006).
Recent estimates suggest that oral HPV infection, which is the cause
of a subset of oropharyngeal squamous cell carcinomas (OSCCs)
(Gillison et al., 2000), is more common in men than in women
(Gillison et al., 2012). In 2006, a three-dose vaccine was approved
for use among females age 9–26 years (Centers for Disease Control
and Prevention, 2007). HPV vaccine guidelines were extended to
males beginning in October of 2009, with a routine vaccination
recommendation beginning in October 2011 (Centers for Disease
Control and Prevention, 2010).Population Health, Florida State
240.
HMJokinengordon@uams.edu
. This is an open access article underAlthough rates of vaccination among adolescent girls have more
than doubled since the vaccine's introduction, current estimates suggest
that progress may be slowing, as there was little change in vaccine up-
take between 2011 and 2012. Most recent estimates suggest that only
one in three adolescent girls have received all three recommended
doses (Centers for Disease Control and Prevention, 2013). Vaccination
rates among adolescent boys are especially low, with fewer than one
in ten receiving any doses of the HPV vaccine (Reiter et al., 2013c). Such
low rates of uptake are disheartening given evidence of the vaccine's
effectiveness. Within 4 years of introduction, the vaccine-type HPV
prevalence decreased markedly among adolescent girls (Markowitz
et al., 2013).
Research suggests that cervical cancer screening, diagnosis,
treatment, and survival vary widely according to sociodemographic
characteristics (Akers et al., 2007; Newmann and Garner, 2005). Socio-
economic deprivation is associated with increased risk of developing
cervical cancer, delayed treatment of the disease, and a highermortality
rate (Akers et al., 2007; Parikh et al., 2003; Singh et al., 2004). African
Americans and Hispanics exhibit higher rates of cervical cancer than
their non-Hispanic White counterparts (Centers for Disease Control
and Prevention, 2012; American Cancer Society, 2013). Rather than re-
ducing social disparities in HPV infection and cervical cancer mortality,
the HPV vaccine could potentially increase disparities according to race,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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males appear to be less likely than their non-Hispanic White counter-
parts to have initiated (Fisher et al., 2013; Gelman et al., 2013; Kessels
et al., 2012) and completed (Dempsey et al., 2011; Kessels et al., 2012;
Kester et al., 2013; Polonijo and Carpiano, 2013) the three-dose HPV
vaccine series. There is some research to suggest an inverse relationship
between parental socioeconomic status andHPV vaccination among ad-
olescents (Kester et al., 2013; Polonijo and Carpiano, 2013; Tiro et al.,
2012), but this ﬁnding is inconsistent in the literature (Fisher et al.,
2013; Kessels et al., 2012). Social variations in HPV vaccination uptake
amongboys are largely unexplored; however, limited evidence suggests
that non-Hispanic White parents are less likely to have vaccinated sons
than parents of other racial and ethnic groups (Reiter et al., 2013c).
Although social determinants of HPV vaccination initiation are rela-
tively well established, research has just begun to identify prevalent ra-
tionales for delaying HPV vaccination, including, for example, not
receiving a recommendation to vaccinate (Darden et al., 2013; Dorell
et al., 2011; Holman et al., 2014; Kester et al., 2013; Reiter et al.,
2013a), reporting that the child was not sexually active (Caskey et al.,
2009; Darden et al., 2013), safety concerns (Caskey et al., 2009;
Darden et al., 2013), and a lack of knowledge about the vaccine
(Dorell et al., 2011; Holman et al., 2014; Reiter et al., 2013a,b). While
this new line of research is informative, few studies have testedwhether
any of these rationales for postponing or forgoing HPV vaccination are
likely to vary according to socioeconomic status (SES), race, ethnicity,
and gender.
Polonijo and Carpiano (2013) note important social inequalities in
both HPV vaccine knowledge and receipt of a health provider's recom-
mendation to vaccinate.More speciﬁcally, they ﬁnd that low SES and ra-
cial/ethnic minority parents display lower odds of knowing about the
vaccine. Further, African American and low SES parents are less likely
to receive a recommendation from a health professional to vaccinate
their daughters. Other research focusing on adolescents in North Caroli-
na suggests that parents of boys are less likely to receive a recommenda-
tion to vaccinate than parents of girls (Gilkey et al., 2012). These
disparities suggest that other important social variations may exist in
reasons for delay in HPV vaccine uptake. Understanding not only who
delays HPV vaccination, but why certain individuals postpone receiving
this critical vaccine may allow public health ofﬁcials to design more
effective interventions focused on addressing the concerns of certain
at-risk subpopulations.
Using data collected from a large, nationally representative sample
of parents of adolescent children, we test whether parental rationales
for delaying HPV vaccination in their teen children vary according to
gender, race/ethnicity, and socioeconomic status. Previous research
identifying key parental reasons for delaying or forgoing adolescent
HPV vaccination has been largely descriptive in nature (Darden et al.,
2013; Kester et al., 2013; Reiter et al., 2013a). While this research is an
important ﬁrst step in understanding why parents may postpone or re-
fuse the HPV vaccine, it does not allow us to identify important sub-
group variations in rationales. Further, much of the research on HPV
attitudes and uptake focuses solely on females (Caskey et al., 2009;
Cassidy and Schlenk, 2012; Conroy et al., 2009; Constantine and
Jerman, 2007; Dempsey et al., 2011; Kohler et al., 2008; Reiter et al.,
2009; Rosenthal et al., 2008; Tiro et al., 2012; Wei et al., 2013), utilizes
small, community samples (Adams et al., 2007; Cassidy and Schlenk,
2012; Conroy et al., 2009; Gerend et al., 2009; Manhart et al., 2011;
Read et al., 2010; Reiter et al., 2009, 2013b; Rosenthal et al., 2008;
Vanderpool et al., 2011), or centers on speciﬁc subpopulations (Guerry
et al., 2011; Perkins et al., 2013; Read et al., 2010). While informative,
results from these studies cannot be generalized beyond these popula-
tion parameters. Previous research has also noted social disparities in
important predictors of HPV vaccination, such as HPV knowledge and
provider recommendation; however, the current study is the ﬁrst to ex-
amine (a) social variations in a wide range of rationales for delaying or
forgoing HPV vaccination and (b) whether social disparities in theserationales explain why parents chose to delay or forgo HPV vaccination
in their adolescent children.
Methods
Data
Our study employs data from the 2011 National Immunization
Survey–Teen (NIS-Teen). The National Center for Immunization and
Respiratory Diseases and the National Center for Health Statistics col-
lected the telephone survey data from a random digit sample of parents
of adolescent children. The NIS-Teen survey implemented a dual-frame
sampling design with independent landline and cell phone samples.
Response rates for these samples are 57.2% and 22.4%, respectively.
The primary aim of the NIS-Teen is to estimate vaccine coverage for
adolescents aged 13–17 based on parental reports. Within recruited
households, the parent or guardian who reported knowing the
most about the adolescent's health was administered a survey asking
about the child's vaccine history. With only a few rare exceptions
(e.g., emancipated minors), teens under 18 must have parental consent
in order to receive the HPV vaccine. Thus, parental reports are prefera-
ble for this age group.
In the ﬁrst set of analyses, we examine the social distribution of pa-
rental reports of vaccine delay. We limited our sample to parents of
those teens who had not yet initiated the HPV vaccination series
(n = 25,229). In the second set of analyses, we limited our sample to
those respondents who reported that they were “not likely at all” to
have their child vaccinated in the next twelve months (n= 9,964). All
estimates were weighted using the protocol for the dual-frame sample
weight detailed in the user guide, which can be found online (Data
User's Guide for the 2011 NIS-Teen Public Use Data File, 2011)
Measures
Parents who reported that their teen had not yet received any doses
of the HPV vaccine were asked how likely it was that their child would
receive the vaccine in the next 12 months. Response categories for this
question ranged from “very likely” to “not likely at all” on a 5-point
scale. Responses to this question were used to create a dichotomous in-
dicator of those parents who were “not likely at all” to have their child
vaccinated in the next year. Parents who did not plan to vaccinate
their teenwere asked to report themain reason(s) for delay by selecting
from a list of eight response categories. Using these measures, we creat-
ed a series of dichotomous variables to indicate the various rationales
for delaying or forgoing theHPV vaccine, including no recommendation,
safety concerns, no perceived need, the teen is male, lack of knowledge
about the vaccine, the teen is not sexually active, age, and “other”
reasons. Parents who reported “other” were asked to specify their rea-
soning, and responses were back coded by NIS-Teen. Parental reasons
for vaccine delay that included less than 2 percent of the sample were
included in the “other” category. The other category includes reasons
such as religion and cost of the vaccine. Although respondents had the
option of selecting more than one reason for forgoing the vaccine, the
majority of the sample reported only one reason (92.3%).
While social variations in rationales for HPV vaccination delay are
largely unexplored, prior research has identiﬁed a number of correlates
of HPV vaccine acceptability and uptake that may help identify barriers
to HPV vaccine initiation, including the child's sex, race and ethnicity
(non-Hispanic White, non-Hispanic Black, Hispanic, other race), age,
maternal education (less than high school, high school degree, some
college, college or higher), and household income (living at or below
poverty level, greater than poverty but less than $75,000, greater than
or equal to $75,000).We also include controls for a number of other po-
tential confounding variables, including insurance status (privately in-
sured, Medicaid, no insurance), the relationship of the respondent to
the child, the number of children in the household, the respondent's
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or younger, 35–44 years, 45 years or older), and the region of residence
(South, Midwest, West, Northeast).
Results
Descriptive statistics for all measures are presented in Table 1. The
ﬁrst column displays information on sample characteristics for the full
sample. Column 2 provides information on the subsample of adoles-
cents who have not initiated the HPV vaccine. Among parents of teens
whohad not yet initiated the vaccine series, a substantial percentage re-
ported that they were not likely at all to do so in the next year (40.3%).
The majority of the full sample were parents of unvaccinated sons
(65.2%), non-Hispanic White (69.5%), married (78.3%), covered by pri-
vate insurance (85.9%), and living well above the poverty line. The typ-
ical respondent was the child's mother (79.1%), 45 years or older (52%)
with at least some college education (28.2%). Among those parents who
did not intend to vaccinate their teen, the most common reason report-
edwas a belief that the vaccinewas not needed (28.8%), followed by re-
ports that their teen is not sexually active (18.2%). Other parents
reported that they did not intend to vaccinate because they had not re-
ceived a recommendation for theHPV vaccine from their doctor or other
medical professional (12.6%), had concerns about the safety of the vac-
cine (12.5%), or felt they did not know enough about the HPV vaccine
(10%). A smallminority of respondents reported that they did not intentTable 1
Demographic and descriptive statistics, National Immunization Survey–Teen, 2011 U.S.
Full sample (SD) Delay sample (SD)
Vaccine delay 40.3
Reported reason for delay
No recommendation 12.6
Safety concern 12.5
No need for the vaccine 28.8
Lack of knowledge 10.0
Teen is not sexually active 18.2
Teen's age 5.7
Other 8.7
Teen is male 9.2
Male 65.2 67.5
Race/ethnicity
Hispanic 12.2 9.2
Black 9.9 9.0
Other 8.4 7.9
Non-Hispanic White 69.6 73.9
Age 14.9 (1.4) 14.9 (1.4)
Federal poverty level (FPL)
N=75 k 45.2 48.2
Greater than poverty, less than 75 k 41.7 43.0
Below federal poverty level 13.1 8.8
Mother's education
Less than high school 7.7 4.2
High school only 19.1 17.5
Some college 28.2 29.9
College graduate 44.9 48.3
Insurance status 7.5
Privately insured 85.9 87.7
Medicaid 6.4 4.8
No insurance 7.6 7.5
Mother respondent 79.1 79.9
Number of children in household 1.7 (0.6) 1.71 (0.6)
Married 78.3 81.2
Mother's age (years)
35 or younger 6.2 5.7
35–44 41.8 42.3
≥45 52.0 52.5
Census region
South 38.7 37.4
Midwest 21.0 22.1
West 22.6 23.6
Northeast 17.8 16.9
n = 25,229 n = 9,964to vaccinate because their teen is male (9.2%) or too young (5.6%).
Finally, approximately 9% of the sample reported some other reason
for delaying or forgoing the HPV vaccine. In comparing the characteris-
tics of the delay sample with the full sample, those who intended to
delay were disproportionally non-Hispanic White, more afﬂuent, and
more highly educated.
Table 2 presents the results of a logistic regression model predicting
the odds of parental reports of being “not likely at all” to vaccinate their
teen within the next 12 months. Among unvaccinated teens, males
displayed an approximate 20% increase (OR = 0.67; CI = 0.62–0.73)
in the odds of continued vaccination delay (OR = 1.20; CI = 1.14–
12.7) in comparison to their female counterparts. Both Hispanic
teens and those adolescents in the “other” race category (OR = 0.85;
CI = 0.77–0.93) displayed lower odds of reporting a further delay in
HPV vaccination uptake in comparison to non-Hispanic White adoles-
cents. Interestingly, adolescents in households with higher levels of
income displayed greater odds of delaying vaccination in comparison
to those teens in households with incomes at or below the poverty
line. Similarly, greater maternal education was associated with in-
creased odds of continued vaccination delay. Teens with mothers who
had less than a high school education (OR = 0.55; CI = 0.48–0.63) or
only a high school education (OR = 0.88; CI = 0.82–0.94) displayed
lower odds of further vaccination delay as compared to those youths
with college educated mothers.
Parents who reported that they were “not likely at all” to vaccinate
their child in the following twelve months were asked the primary rea-
son for delaying or forgoing the vaccine. As shown in Table 3, therewere
notable gender variations in rationales for delaying HPV vaccination.
Parents of boys were more than twice as likely to report not receiving
a recommendation to vaccinate as the primary reason for delaying vac-
cination (OR= 2.57; CI = 2.20–3.01) in comparison to parents of girls.
Likewise, parents of sons displayed increased odds of delaying orTable 2
Logistic regression of reporting “not likely” to initiate vaccination sequence in next 12
months, National Immunization Survey–Teen, 2011 U.S.
OR 95 % CI
Male 1.20*** 1.14–1.27
Racea
Hispanic 0.67*** 0.62–0.73
Black 0.93 0.84–1.01
Other 0.85*** 0.77–0.93
Age 0.98 0.96–1.00
Household incomeb
≥75 k 1.37*** 1.23–1.53
Greater than poverty, less than 75 k 1.49*** 1.33–1.61
Mother's educationc
Less than high school 0.55*** 0.48–0.63
High school only 0.88*** 0.82–0.94
Some college 1.02 0.95–1.08
Mother respondent 1.07* 1.01–1.15
Number of children in household 1.11*** 1.06–1.15
Married 1.15*** 1.08–1.24
Mother's age (years)d
35–44 1.17** 1.04–1.29
≥45 1.16* 1.02–1.27
Insurance coveragee
Medicaid 0.88* 0.78–0.98
No insurance 1.06 0.95–1.17
Census regionf
South 1.11** 1.03–1.19
Midwest 1.17*** 1.08–1.27
West 1.23*** 1.14–1.33
Constant 0.34***
N = 25,229
Note. OR = odds ratio. Omitted categories: aWhite (non-Hispanic), bpoverty or less,
ccollege degree, dless than or equal to 34 yrs, eemployer, fnortheast. *p b 0.05,
**p b 0.01, ***p b 0.001.
Table 3
Logistic regression of rationales for delaying HPV vaccination uptake, National Immunization Survey–Teen, 2011 U.S.
No recommendation Safety concerns No need Lack of knowledge
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Male 2.57*** 2.20–3.01 0.28*** 0.24–0.31 1.22*** 1.10–1.34 1.08 0.94–1.25
Racea
Hispanic 1.14 0.91–1.38 1.14 0.91–1.35 0.99 0.85–1.15 1.39** 1.11–1.72
m 1.11 0.85–1.31 0.77* 0.65–0.92 1.20* 1.03–1.39 1.49*** 1.19–1.85
Other 1.41** 1.13–1.73 0.72** 0.56–0.92 1.00 0.85–1.18 1.43** 1.13–1.80
Age 1.01 0.98–1.07 1.02 0.97–1.07 1.02 0.98–1.05 1.03 0.98–1.08
Household incomeb
Greater than or equal to 75 k 1.01 0.79–1.29 1.30 0.99–1.70 1.07 0.88–1.29 0.94 0.71–1.22
Greater than poverty, less than 75 k 0.87 0.70–1.09 1.33* 1.03–1.70 1.16 0.95–1.31 0.96 0.74–1.22
Mother's educationc
Less than high school 0.99 0.82–1.46 0.96 0.68–1.35 1.06 0.84–1.34 1.29 0.97–1.79
High school only 1.00 0.83–1.19 1.07 0.89–1.29 1.13 0.99–1.28 1.17 0.96–1.42
Some college 0.85* 0.73–0.99 1.06 0.91–1.23 1.01 0.91–1.12 1.10 0.94–1.29
Mother respondent 0.68*** 0.59–0.78 1.74*** 1.45–2.08 0.75*** 0.67–0.83 1.21* 1.02–1.44
Number of children in household 0.96 0.89–1.06 1.06 0.96–1.18 1.08* 1.00–1.63 0.93 0.83–1.04
Married 0.99 0.83–1.15 0.91 0.78–1.07 1.18** 1.05–1.34 1.07 0.90–1.28
Mother's age (years)d
35–44 1.25 0.91–1.472 0.98 0.75–1.29 0.98 0.81–1.18 1.14 0.84–1.56
≥45 1.35 0.97–1.86 0.91 0.69–1.20 0.97 0.80–1.19 0.96 0.70–1.33
Insurance status
Medicaid 1.14 0.84–1.54 1.25 0.93–1.67 0.97 0.78–1.21 0.97 0.71–1.33
No insurance 0.85 0.67–1.09 0.89 0.70–1.14 1.10 0.94–1.31 1.09 0.85–1.39
Census regione
South 0.78** 0.66–0.93 0.93 0.78–1.00 1.11 0.97–1.25 0.94 0.78–1.14
Midwest 1.04 0.59–0.87 0.83 0.69–1.00 1.08 0.94–1.25 0.85 0.68–1.04
West 0.73** 0.60–0.88 0.75** 0.62–0.91 1.31*** 1.14–1.51 0.79* 0.64–0.98
Constant 0.08*** 0.12*** 0.19*** 0.06***
N = 9,964
Not sexually active Teen's age Other reason Teen is male
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Male 0.68*** 0.61–0.75 0.64*** 0.54–0.77 0.54*** 0.47–0.63 – –
Racea
Hispanic 0.72** 0.59–0.88 1.23 0.92–1.65 0.81 0.62–1.05 0.81 0.62–1.06
Black 0.83 0.68–1.00 0.62* 0.42–0.91 0.84 0.65–1.10 0.83 0.64–1.09
Other 0.81* 0.66–0.98 0.95 0.68–1.31 1.12 0.88–1.45 0.75 0.56–1.01
Age 0.94** 0.91–0.98 0.56*** 0.52–0.61 1.14*** 1.09–1.21 1.05* 1.01–1.11
Household incomeb
≥75 k 0.86 0.69–1.07 1.23 0.84–1.82 0.62** 0.46–0.82 1.32 0.96–1.83
Greater than poverty, less than 75 k 0.92 0.75–1.13 0.97 0.67–1.40 0.84 0.65–1.09 1.11 0.83–1.51
Mother's Educationc
Less than high school 0.78 0.58–1.04 1.31 0.84–2.05 0.93 0.65–1.33 0.74 0.48–1.14
High school only 0.73*** 0.62–0.86 0.91 0.69–1.20 0.97 0.79–1.19 0.72** 0.58–0.90
Some college 0.99 0.87–1.11 0.95 0.77–1.18 0.94 0.79–1.12 0.98 0.83–1.17
Mother respondent 1.08 0.95–1.23 1.25 0.99–1.57 1.19 0.99–1.44 1.50*** 1.24–1.81
Number of children in household 1.01 0.93–1.11 0.93 0.79–1.08 0.91 0.81–1.03 1.05 0.93–1.18
Married 1.04 0.90–1.20 1.13 0.87–1.47 1.11 0.91–1.35 0.70*** 0.58–0.85
Mother's age (years)d
35–44 0.87 0.68–1.11 1.00 0.68–1.48 0.90 0.65–1.24 0.68* 0.50–0.94
N=to 45 1.08 0.84–1.40 1.10 0.74–1.64 0.74 0.53–1.04 0.68* 0.49–0.94
Insurance status
Medicaid 0.99 0.79–1.29 0.92 0.57–1.49 1.06 0.76–1.48 0.98 0.67–1.41
No insurance 0.95 0.78–1.17 1.09 0.75–1.54 1.33* 1.04–1.70 0.97 0.74–1.29
Census regione
South 1.05 0.91–1.23 0.77* 0.60–0.98 1.10 0.88–1.36 1.15 0.94–1.41
Midwest 0.96 0.81–1.14 0.91 0.70–1.19 1.09 0.86–1.37 0.93 0.74–1.17
West 1.13 0.95–1.32 0.70* 0.53–0.92 1.12 0.89–1.42 0.84 0.67–1.06
Constant 0.76 5.62*** 0.03*** 0.09***
N = 9,964 N = 6,726
Note. OR = odds ratio. Omitted categories: aWhite (non-Hispanic), bpoverty or less, ccollege degree, dless than or equal to 34 yrs, eemployer, fnortheast. *p b 0.05, **p b 0.01, ***p b 0.001.
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(OR = 1.22; CI = 1.10–1.34) in comparison to parents of daughters.
Conversely, parents of adolescent boys displayed lower odd of citing
concerns about vaccine safety and side effects (OR = 0.28; CI = 0.24–
0.31), a lack of sexual activity (OR = 0.68; CI = 0.61–0.75), or the
child's age (OR = 0.64; CI = 0.54–0.77) as a reason for vaccination
delay in comparison to parents of adolescent girls.Our results also revealed notable racial and ethnic differences in
reasons for delaying or forgoing the HPV vaccine. Black (OR = 0.77;
CI = 0.65–0.92) and other race parents (OR = 0.72; CI = 0.56–0.92)
both displayed reduced odds of citing safety concerns as the primary
reason for delaying vaccination in comparison to non-Hispanic White
parents. Conversely, African American parents (OR = 1.20; CI = 1.03–
1.39) displayed greater odds of reporting that the delay in initiation
25A.M. Burdette et al. / Preventive Medicine Reports 1 (2014) 21–26was because the HPV vaccine was not needed in comparison to their
non-Hispanic White counterparts. Hispanic (OR = 1.39; CI = 1.11–
1.72), Black (OR = 1.49; CI = 1.19–1.85), and other race (OR = 1.43;
CI = 1.13–1.80) parents all displayed signiﬁcantly higher odds of
reporting that a lack of knowledge about the HPV was the primary bar-
rier to adolescent vaccination in comparison to non-Hispanic White
parents. Hispanic (OR = 0.72; CI = 0.59–0.88) and other race parents
(OR = 0.81; CI = 0.66–0.98) displayed reduced odds of reporting that
they were delaying or forgoing the vaccine because their child was not
sexually active in comparison to non-Hispanic White parents. Black
parents (OR= 0.62; CI= 0.42–0.91) displayed lower odds of reporting
age as the reason for vaccine delay in comparison to non-Hispanic
White parents.
Socioeconomic status was also associated with HPV rationales in
our data. Those who reported “some college” as the level maternal
education displayed reduced odds of selecting no recommendation
(OR = 0.86; CI = 0.74–0.99), as the reason for delay in comparison to
mothers with a college degree. Adolescents with high school educated
mothers displayed reduced odds of receiving the vaccine due to being
male (OR = 0.72; CI = 0.58–0.90), or not being sexually active
(OR = 0.73; CI = 0.62–0.86), in comparison to mothers with a college
degree. Parentswith household incomes in themiddle income category,
above the federal poverty level but less than $75,000, (OR= 1.28; CI =
1.00–1.63), displayed signiﬁcantly greater odds of reporting safety
concerns as a key reason for delaying HPV vaccination uptake in com-
parison to parents with lower incomes.
Discussion
Social determinants of rationales for delaying or forgoing the HPV
vaccine remain underexplored despite research noting signiﬁcant vari-
ations in HPV vaccination initiation by gender, race/ethnicity, and socio-
economic status (Kester et al., 2013; Polonijo and Carpiano, 2013; Reiter
et al., 2013c; Tiro et al., 2012).We examine these social variations in pa-
rental reasons for delaying the initiation of HPV vaccine in their adoles-
cent children using data from the 2011 NIS-Teen, a nationally
representative sample detailing vaccination coverage in United States
among adolescents aged 13–17. Our results reveal a number of patterns
of concern to practitioners interested in reducing social disparities in
HPV vaccination uptake.
To begin, gender variations in HPV vaccination uptake appear to be
driven by a lack of recommendation from health care professionals,
with parents of boys being much less likely to receive a recommenda-
tion to vaccinate than parents of teen girls. Gender disparities in uptake
are not surprising given that the recommendation to vaccinate against
HPV was not extended to boys until 2009. However, a recent review
suggests that both parents and medical professionals believe that the
consequences of HPV infection are less severe formales than for females
and therefore not worth the cost or effort of vaccinating against
(Holman et al., 2014). Taken together with our ﬁndings, this research
suggest that gender disparities in HPV vaccination uptake are unlikely
to be reduced without substantial public health efforts to educate both
parents and health care providers about the beneﬁts of the vaccine
and the potential health consequences of HPV infection for males.
Our results also revealed a number of racial and ethnic variations in
rationales for delaying or forgoing the HPV vaccine. Hispanic, African
American, and other race parents all displayed increased odds of
reporting that a lack of knowledge about the HPV was the primary bar-
rier to vaccination in comparison to non-HispanicWhite parents. Racial
and ethnic minority parents were also less likely to give other reasons
(e.g., the child's age or safety concerns). These ﬁndings suggest that in-
terventions focused on educating the parents of minority youth on the
beneﬁts of the HPV vaccinemay be successful in reducing current racial
and ethnic disparities in initiation (Fisher et al., 2013; Gelman et al.,
2013; Kessels et al., 2012) and completion (Dempsey et al., 2011;
Kessels et al., 2012; Kester et al., 2013; Polonijo and Carpiano, 2013)of the 3 dose HPV vaccine series, as well as similar disparities in cervical
cancer (Centers for Disease Control and Prevention, 2012; American
Cancer Society 2013). Reducing the delay in timing of HPV vaccination
among African American teens is of critical importance given that
African American adolescents transition to ﬁrst sex earlier than teens
of other racial and ethnic groups, and for prophylactic vaccination to
be most effective it should occur prior to sexual initiation (Adams
et al., 2007).
Finally, our results showed few socioeconomic differences in the
reasons parents give for delaying HPV uptake in their adolescent
children. The few sporadic ﬁndings revealed in our data favored lower
socioeconomic parents, suggesting that a lack of knowledge about the
vaccine or concerns about vaccine safety are not a major barrier to
HPV vaccination among this group. In fact, results from both Tables 2
and 3 suggest that interventions centered on increasing HPV vaccina-
tion rates should focus on parents of higher socioeconomic status
adolescents, who appear to have more concerns about the vaccine
than their less educated and less afﬂuent counterparts.
One important limitation of this research underscores the need for
caution in interpreting these ﬁndings and the need for further research
into the links between social characteristics and parental rationales for
delaying or forgoing the HPV vaccine. Consistent with the majority of
studies in this area (Dorell et al., 2011, 2014; Reiter et al., 2013a,c), we
rely on parental reports of provider recommendations, which may be
subject to recall bias.
Despite this limitation, our results revealed several notable and ro-
bust associations between key social characteristics and parental ratio-
nales for delaying or forgoing HPV vaccination in adolescent children.
Because uptake of the HPV vaccine remains low, understanding social
disparities in reasons for delaying vaccination is critical to designing in-
terventions focused on alleviating the concerns of parents. Our results
suggest that these interventions might speciﬁcally focus on increasing
information about the beneﬁts of theHPV vaccine among parents ofmi-
nority youth—a groupwith elevated risk of acquiring HPV and develop-
ing cervical cancer. Our ﬁndings also suggest that interventions
targeting health care providersmay also be a useful strategy for improv-
ing vaccine uptake among adolescent males.Conﬂict of interest statement
The authors declare that there are no conﬂicts of interests.References
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